STAT5A was recently shown to be overexpressed, along with EPHA2, in HNSCC, and this signaling pair was found to positively predict response to chemoradiation therapy; STAT1 and STAT3 were overexpressed as well58. This evidence concerns the gene STAT5A and head and neck squamous cell carcinoma.